Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

1.2K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.2K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular and neuronal ischemic damage in cryonics patients.

Rejuvenation research·2012
Same author

Nuclear DNA damage as a direct cause of aging.

Rejuvenation research·2009
Same author

Scientific justification of cryonics practice.

Rejuvenation research·2008
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Measuring the Densities of Aqueous Glasses at Cryogenic Temperatures
09:50

Measuring the Densities of Aqueous Glasses at Cryogenic Temperatures

Published on: June 28, 2017

9.2K

Cryoprotectant Toxicity: Facts, Issues, and Questions.

Benjamin P Best1

  • 1Life Extension Foundation , Coconut Creek, Florida.

Rejuvenation Research
|April 1, 2015
PubMed
Summary

Cryoprotective agents (CPAs) are crucial for cryopreservation but their toxicity limits effectiveness. This review explores CPA toxicity mechanisms and strategies to minimize harm for successful organ cryopreservation.

Area of Science:

  • Biotechnology
  • Cryobiology
  • Cellular Biology

Background:

  • High concentrations of penetrating cryoprotectants (CPAs) prevent ice formation during cryopreservation.
  • Increasing CPA concentrations lead to heightened cellular toxicity, posing a significant challenge.
  • Current strategies to mitigate CPA toxicity are insufficient for widespread application.

Purpose of the Study:

  • To review the current understanding of cryoprotectant agent toxicity.
  • To explore theoretical mechanisms underlying CPA toxicity.
  • To analyze existing and propose novel strategies for reducing CPA toxicity in cryopreservation.

Main Methods:

  • Literature review of cryoprotectant agents and toxicity studies.
  • Analysis of theoretical models explaining CPA-induced cellular damage.

More Related Videos

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.9K
Bulk Droplet Vitrification for Primary Hepatocyte Preservation
11:07

Bulk Droplet Vitrification for Primary Hepatocyte Preservation

Published on: October 25, 2019

6.2K

Related Experiment Videos

Last Updated: Apr 15, 2026

Measuring the Densities of Aqueous Glasses at Cryogenic Temperatures
09:50

Measuring the Densities of Aqueous Glasses at Cryogenic Temperatures

Published on: June 28, 2017

9.2K
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.9K
Bulk Droplet Vitrification for Primary Hepatocyte Preservation
11:07

Bulk Droplet Vitrification for Primary Hepatocyte Preservation

Published on: October 25, 2019

6.2K
  • Critical evaluation of current and emerging strategies for toxicity mitigation.

    • Main Results:

    • CPA toxicity is a primary barrier to successful cryopreservation of cells, tissues, and organs.
    • Existing methods for optimizing cooling rates and CPA addition timing show limited success in reducing toxicity.
    • A comprehensive understanding of CPA toxicity mechanisms is lacking.

    Conclusions:

    • CPA toxicity remains the most significant obstacle to achieving effective cryopreservation, particularly for human organs.
    • Further research into CPA toxicity mechanisms and innovative reduction strategies is essential.
    • Overcoming CPA toxicity is critical for advancing organ transplantation and regenerative medicine.